Home
News
Create
Screeners
Insights
Aarey Drugs & Pharmaceuticals
97.
26
-1.99
(-2.01%)
Market Cap
₹275.80 Cr
PE Ratio
66.33
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-2.01%
1M
+15.79%
6M
+84.10%
1Y
+52.02%
5Y
+124.36%
View Company Insights
Latest news about Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals Announces Share Capital Increase and Preferential Issue Plans
Sep 06, 2025
Aarey Drugs & Pharmaceuticals Ltd has approved an increase in Authorised Share Capital from Rs. 255.00 crores to Rs. 355.00 crores. The company plans a preferential issue of 50 lakh equity shares and 50 lakh warrants convertible into equity shares. These proposals are subject to shareholder approval at the upcoming AGM on September 5, 2023. The company's recent financial results show a 17.72% increase in revenue to Rs. 473.94 crores, but a 10.85% decrease in net profit to Rs. 4.19 crores.
Aarey Drugs & Pharmaceuticals Reports Q1 Results: Revenue Dips, Profit Rises
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation